ReviewFrontiers in microbiology2026
The microgenderome in migraine: integrating sex hormones, microbial composition, and metabolic profiles into a sex-related framework.
Review in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Migraine is a debilitating neurological disorder with marked sex differences, as women experience a prevalence two to three times higher than men. Although the gut-brain axis has been implicated in migraine biology, the intersection of sex hormones, microbial signaling, and microbial metabolites remains underexplored. This review evaluates migraine-specific and mechanistically relevant evidence on sex-related microbial and metabolic profiles to examine their potential relevance to sex-related characteristics of migraine. Methods: This narrative review was informed by a structured literature search of PubMed through May 2026, identifying 22 relevant studies, including clinical studies, interventional studies, animal models, and mechanistic investigations. Given heterogeneity in study design, sequencing methods, sampling strategies, clinical populations, and outcome measures, evidence was synthesized narratively to develop a hypothesis-generating framework for interactions among sex hormones, microbiota, microbial metabolites, and migraine. Results: Current evidence suggests that gut microbial diversity and composition may be altered in migraine, but sex-stratified migraine-specific data remain limited. Female migraine cohorts have shown reduced abundances of taxa such as Conclusion: The sex hormone-microbiota-metabolite-brain axis should be considered a hypothesis-generating framework rather than an established causal mechanism for migraine sex differences. Future research should use sex-balanced longitudinal cohorts, menstrual-cycle-aware sampling, migraine-specific models, and integrated multi-omics to validate candidate pathways and determine whether microbiome-related signatures can inform sex-stratified biomarkers or adjunctive microbiome-targeted interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.